markets

Exascale Labs, BCAR Set July 29 Shareholder Vote on Merger

Exascale Labs and D. Boral ARC Acquisition I Corp. have scheduled an extraordinary general meeting for July 29, 2026 to vote on their proposed business combination.

Exascale Labs and D. Boral ARC Acquisition I Corp. (BCAR) announced Wednesday that shareholders will convene in an extraordinary general meeting on July 29, 2026, to cast votes on a proposed business combination between the two companies. The meeting marks a critical milestone in the merger process, requiring shareholder approval before the deal can advance to closing.

SPAC mergers like this one hinge on shareholder consent, and scheduling the vote signals that both parties have cleared the regulatory and procedural hurdles necessary to bring the transaction to a formal ballot. D. Boral ARC Acquisition I Corp. is a special purpose acquisition company, meaning its primary purpose is to identify and merge with a target — in this case, Exascale Labs.

Read more Nvidia Bucks Chip Sector Selloff as Traders Bet on Rebound →

Exascale Labs, by agreeing to the combination, would gain access to public markets through the SPAC structure, a route that bypasses the traditional IPO process. The outcome of the July 29 vote will determine whether the merged entity moves forward as a publicly traded company. Investors and market observers will be watching BCAR closely in the weeks ahead as the meeting date approaches.

Continue reading at GlobalNewswire.

Continue reading at GlobalNewswire →

Frequently Asked Questions

Q.When is the BCAR extraordinary general meeting scheduled?

The extraordinary general meeting of D. Boral ARC Acquisition I Corp. shareholders is scheduled for Wednesday, July 29, 2026.

Q.What will shareholders vote on at the BCAR meeting?

Shareholders will vote on approving the proposed business combination between D. Boral ARC Acquisition I Corp. and Exascale Labs.

Q.What is D. Boral ARC Acquisition I Corp.?

D. Boral ARC Acquisition I Corp., trading under the ticker BCAR, is a special purpose acquisition company formed to identify and complete a merger with a target business, which in this case is Exascale Labs.

More in markets →